InsiderCow.com

Medgenics Inc (NASDAQ: GNMX), which recently changed its official name to Aevi Genomic Medicine, was seen up 28.3 percent Thursday after a new SEC filing revealed that seven company insiders, including CEO Michael Cola, have been buying shares of the company’s stock. Together, the seven...

Potentially investing thousands of hard-earned dollars in a stock can be a very difficult decision for the average American. It’s always difficult to trust company management because part of their job is to put a positive spin on the company’s business. Prior to every bankruptcy filing...